PADRINI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.478
EU - Europa 1.422
AS - Asia 1.199
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 12.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.463
CN - Cina 568
SG - Singapore 427
FI - Finlandia 251
IT - Italia 225
DE - Germania 224
GB - Regno Unito 211
FR - Francia 163
VN - Vietnam 163
UA - Ucraina 161
SE - Svezia 144
IN - India 24
NL - Olanda 17
CA - Canada 9
IE - Irlanda 7
HK - Hong Kong 6
TR - Turchia 4
AT - Austria 3
MX - Messico 3
PE - Perù 3
BE - Belgio 2
CZ - Repubblica Ceca 2
ES - Italia 2
EU - Europa 2
KR - Corea 2
NI - Nicaragua 2
PL - Polonia 2
RO - Romania 2
RU - Federazione Russa 2
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 12.106
Salva come PNG Salva come JPEG
Città #
Fairfield 1.373
Woodbridge 894
Chandler 770
Jacksonville 743
Houston 704
Ann Arbor 647
Ashburn 566
Wilmington 552
Seattle 491
Cambridge 488
Singapore 342
Princeton 304
Boardman 251
Dong Ket 163
Santa Clara 152
Beijing 142
San Diego 133
Nanjing 112
Des Moines 102
Medford 101
Roxbury 97
Helsinki 86
Padova 84
Munich 41
Shenyang 35
Nanchang 32
Guangzhou 28
Norwalk 28
Changsha 25
Jiaxing 23
London 19
Tianjin 18
Redwood City 16
Rome 14
New York 13
Hebei 12
Jinan 12
Kharkiv 11
Kilburn 9
Milan 9
Ogden 9
Dublin 7
Hefei 7
Ningbo 7
Shanghai 7
Hong Kong 6
Zhengzhou 6
Borås 5
Chicago 5
Lendinara 5
Saarbrücken 5
Indiana 4
Kunming 4
Mountain View 4
Phoenix 4
San Giovanni a Piro 4
Apodaca 3
Aversa 3
Ferrara di Monte Baldo 3
Frankfurt am Main 3
Lima 3
Mestre 3
Negrar 3
New Bedfont 3
Pontecchio Polesine 3
Taiyuan 3
Washington 3
Albignasego 2
Amsterdam 2
Battipaglia 2
Bologna 2
Campobasso 2
Cankaya 2
Castegnero 2
Chiswick 2
Esslingen am Neckar 2
Fuzhou 2
Hangzhou 2
Hounslow 2
Lanzhou 2
Legnaro 2
Madrid 2
Managua 2
Messina 2
Miami 2
Monmouth Junction 2
Mumbai 2
Plymouth 2
Ponte di Piave 2
Pune 2
Radomsko 2
Redmond 2
Rockville 2
San Francisco 2
Secaucus 2
Siena 2
Syracuse 2
Taizhou 2
Taormina 2
Vancouver 2
Totale 9.830
Salva come PNG Salva come JPEG
Nome #
Phthalates and heavy metals as endocrine disruptors in food: A study on pre-packed coffee products 336
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 162
Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer’s disease 142
Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors 139
Monitoring Plasma Levels of Donepezil, 5-O-Desmethyl-Donepezil, 6-O-Desmethyl-Donepezil, and Donepezil-N-Oxide by a Novel HPLC Method in Patients with Alzheimer Disease 130
A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty. 127
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. 122
Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil 120
Macrolides for KCNJ5–mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism 119
Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms 116
Perioperative Analgesic Efficacy and Plasma Concentrations of S(+)-Ketamine in Continuous Epidural Infusion During Thoracic Surgery. 114
Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours 113
Combinations of Polymorphisms in Genes Involved in the 5-Fluorouracil Metabolism Pathway Are Associated with Gastrointestinal Toxicity in Chemotherapy-Treated Colorectal Cancer Patients 111
A pharmacokinetic-pharmacodynamic model for individualisation of an oral anticoagulation therapy 111
VERAPAMIL AND NORVERAPAMIL PLASMA-LEVELS IN INFANTS AND CHILDREN DURING CHRONIC ORAL TREATMENT 110
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 109
Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders 109
R-warfarin anticoagulant effect 109
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 106
Identifying type Vicenza von Willebrand disease 106
Effect of CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function 106
A model-based approach to the automatic diagnosis of von Willebrand disease 106
Ranolazine-Induced Severe Bladder Hypotonia 105
Classification of thymidylate synthase gene enhancer region polymorphisms 104
A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2C9, VKORC1, and age 104
Pharmacokinetics of Pentoxifylline and Its Main Metabolites in Patients With Different Degrees of Heart Failure Following a Single Dose of a Modified-Release Formulation 101
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study 101
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 99
Antiarrhythmic drug plasma concentrations in ambulatory patients 97
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 95
Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardium 94
DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC-UV in apixaban- and rivaroxaban-treated patients from the START-Register 93
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis 92
AJMALINE TEST IN A PATIENT WITH CHRONIC-RENAL-FAILURE - A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY 91
A Mechanistic Model to Quantify von Willebrand Factor Release, Survival and Proteolysis in Patients with von Willebrand Disease 91
DETERMINATION OF LORAJMINE AND ITS METABOLITE AJMALINE IN PLASMA AND URINE BY A NEW HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD 89
A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy 89
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia. 89
Digitalis glycosides and plasma renin activity 88
Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man 88
A model-based support for diagnosing von Willebrand disease 88
Adaptation of the QT interval to heart rate changes in isolated perfused guinea-pig heart: influence of amiodarone and d-sotalol. 87
Age affects pegylated liposomal doxorubicin elimination and tolerability in patients over 70 years old 87
Effects of phospholipase C on the electrical and mechanical activity of guinea pig taenia coli. 87
A novel G/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele 86
EFFECTS OF PINACIDIL IN ISOLATED PERFUSED GUINEA-PIG HEART 86
Long-term persistence of antianginal effect of oral verapamil in chronic stable angina 86
Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes 85
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 85
Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties 85
Verapamil and norverapamil plasma levels in infants and children during chronic oral treatment 84
Once per week oral administration of amiodarone in the prophylaxis of supraventricular paroxysmal tachycardia 84
Oral Metronomic Vinorelbine (OMV) in elderly or pretreated patients with advanced non small cell lung cancer: outcome and pharmacokinetics in the real world 84
Neurohumoral effects of digitalis 82
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms 82
Frequency of uridine monophosphate synthase Gly(213)Ala polymorphism in Caucasian gastrointestinal cancer patients and healthy subjects, investigated by means of new, rapid genotyping assays 81
EFFECTS OF PINACIDIL ON GUINEA-PIG ISOLATED PERFUSED HEART WITH PARTICULAR REFERENCE TO THE PROARRHYTHMIC EFFECT 81
Effects of cardiopulmonary bypass on vancomycin plasma concentration decay. 79
Effect of dobutamine on left ventricular relaxation and filling phase in patients with ischemic heart disease and preserved systolic function 79
Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable? 79
INHIBITORY EFFECT OF BERBERINE ON AGONIST-INDUCED CONTRACTION OF GUINEA-PIG AORTIC STRIPS 79
Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers 78
Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer 77
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 77
Towards model-based diagnosis of von Willebrand disease 76
Apolipoprotein E (APOE) and warfarin dosing in an Italian population. 75
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 75
Effects of chronic renal failure and hemodialysis on the monoethylglycinexylidide liver function test. 74
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. 74
Present and future trends in research and clinical applications of inodilators. 73
Morphological algebraic models of the the TU-wave patterns in idiopathic long QT syndrome 72
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer. 71
A model-based protocol for the diagnosis of von Willebrand disease 71
Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer 69
CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences 69
Use of oral verapamil in long-term treatment of neonatal, paroxysmal supraventricular tachycardia. A pharmacokinetic study 69
FARMACOLOGIA CLINICA DELL'IPERTENSIONE ARTERIOSA 68
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 68
The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer 68
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 67
The calcium-channel blocker, Verapamil, does not improve portal pressure in patients with alco¬holic cirrhosis. 67
Vasorelaxant effects of norbormide, a selective vasospastic agent for the rat microvasculature 67
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer 67
Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure 67
Column liquid chromatographic determination of prajmalium in plasma and urine by direct sample injection 65
Renal clearance of N-1-Methylnicotinamide is a marker of liver dysfunction in cirrhosis 64
Renal excretion and diuretic effect of furosemide in patients with ascitic liver cirrhosis 64
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 64
Pharmacodynamic variability of flecainide assessed by QRS changes 63
Correlations between the enantio- and regio-selective metabolisms of warfarin 63
UNDULY ENHANCED RESPONSE TO TOLVAPTAN IN A WOMAN SHOWING SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION: AN INVESTIGATION OF POSSIBLE CAUSES 63
Algebraic decomposition of the TU wave morphology patterns 62
Amiodarone and amiodarone plus digitalis in the treatment of paroxismal supraventricular reciprocatine tachyarrhythmias 62
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 60
Effect of hemodialysis on the metabolic clearance of 5-Fluorouracil in a patient with end-stage renal failure. Ther Drug Monit. 2005 Dec;27(6):816-8. 60
G>C SNP of thymidylate synthase with respect to colorectal cancer.Pharmacogenomics. 2007 Aug;8(8):985-96.PMID: 17716232 60
Twenty four-hour continuous indirect blood pressure monitoring during treatment with slow release metoprolol and atenolol 59
Convective and adsorptive removal of β2-microglobulin during predilutional and postdilutional hemofiltration 59
Evaluation of Serum/Urine Genomic and Metabolomic Profiles to Improve the Adherence to Sildenafil Therapy in Patients with Erectile Dysfunction 59
Teicoplanin concentrations in serum, pericardium, pericardial fluid and thoracic wall fat in patients undergoing cardio-pulmonary bypass surgery 58
Totale 8.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.662
article - articoli 36.541
book - libri 160
conference - conferenze 0
curatela - curatele 0
other - altro 109
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.635
Totale 80.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.662 0 0 0 0 229 186 202 290 253 259 129 114
2020/20211.801 57 148 54 118 48 175 51 172 291 203 223 261
2021/20221.973 61 301 185 163 79 120 71 212 91 39 213 438
2022/20231.679 382 155 26 181 288 237 10 109 211 9 63 8
2023/2024652 31 121 93 60 38 37 32 17 18 15 102 88
2024/20251.002 9 282 173 160 378 0 0 0 0 0 0 0
Totale 12.179